Saturday, 28 March 2015 Login

Choose your language

Download 52-page Magazine

time2online Extensions: Simple Video Flash Player Module

ASNS Tweets

Login Form

Login

Home Health Health
Health

A new public-private funded project to combat carbapenem resistance

PDF | Print | E-mail

Written by Kevin Wafula

18 European academic partners and three pharmaceutical companies are launching a new project Wednesday under the Innovative Medicines Initiative (IMI) funded New Drugs 4 Bad Bugs (ND4BB) program: COMBACTE-CARE. COMBACTE-CARE (Combatting Bacterial resistance in Europe-Carbapenem-Resistance) will bring highly innovative studies and activities related to the treatment of patients with infections caused by Carbapenem-Resistant Enterobacteriaceae (CRE).

Read more...

 
 

Sub Saharan Africans enrolled in phase 3 clinical trial of new promising TB drug

PDF | Print | E-mail

Written by Kevin Wafula

A global phase 3 clinical trial named STAND (Shortening Treatment by Advancing Novel Drugs) in patients who are currently considered to have either drug-sensitive or multidrug-resistant TB has been launched by the TB Alliance and its partners. The Alliance announced that enrolment has begun in Kenya, South Africa, Tanzania, Uganda, and Zambia among others.

Read more...

 
 

African education should accommodate older persons, Summit urges

PDF | Print | E-mail

Written by Mamadou A.

A three day continental summit on higher education summit in Dakar, Senegal urged Africa to develop higher education systems that accommodate older learners seeking higher education and provide robust life-learning.

Read more...

 
 

Australia leading the change for women in Kenya

PDF | Print | E-mail

Written by Ruth Akinyi

An Australian-funded scheme is saving and transforming lives in the Rift Valley, Nyanza, Eastern and Coast region in Kenya.  With funding from the Australian Government, Kenyan NGOs have improved the health of more than 52,000 women and children. The funding provides modern family planning methods, child vaccinations, and safe and clean baby delivery services.

Read more...

 
 

Merck Germany Expands Diabetes, Thyroid Dysfunction education in collaboration with Academia From Africa to Asia

PDF | Print | E-mail

Written by Kevin Wafula

Merck, the world’s oldest pharmaceutical and chemical company has widened its global fight against diabetes and thyroid dysfunction from Africa to Asia. Following three years of success providing education and awareness creation and advocacy for medical and pharmacy students in African Universities, Merck has extended its Capacity Advancement Program (CAP) initiative to Asia through forging a partnership with University of Indonesia and Maharashtra University to boost diabetes and thyroid dysfunction healthcare capacity in India and Indonesia.

Read more...

 
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  •  End 
  • »

Page 1 of 82